script. E. H. participated in monitoring data collection, analysis andinterpretation and provided critical revisions to the manuscript. E. H.is the guarantor of this work and, as such, had full access to all datain the study and takes responsibility for the integrity of the data andthe accuracy of the data analysis. ORCID Cristian Guja http://orcid.org/0000-0002-8703-0522 Juan P. Frías http://orcid.org/0000-0001-9486-1255 Serge Jabbour http://orcid.org/0000-0002-4080-0470 Julio Rosenstock http://orcid.org/0000-0001-8324-3275 REFERENCES 1.American Diabetes Association. Standards of medical care in diabe- tes—2017: Classification and diagnosis of diabetes. Diabetes Care . 2017;40(suppl 1):S11-S24. 2.Grandy S, Shaunik A, Hardy E. Effects of glucagon-like peptide-1 receptor agonists on beta-cell function in patients with type 2 diabe-tes. J Diabetes Metab . 2016;7:643. 3.American Diabetes Association. Standards of medical care in diabe-